Xeroderma pigmentosum complementation group D polymorphism toward lung cancer susceptibility survival and response in patients treated with platinum chemotherapy
General Info
Coverage type
Subnational
Time period covered
January, 2016 - December, 2016
Data type
Scientific literature
Citation
Journal
Future Oncol
Pages
2645-2665
Publication year
2017
Suggested citation
Lawania S, Singh N, Behera D, Sharma S. Xeroderma pigmentosum complementation group D polymorphism toward lung cancer susceptibility survival and response in patients treated with platinum chemotherapy. Future Oncol. 2017; 13(29): 2645-2665.